GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Milestone Scientific Inc (AMEX:MLSS) » Definitions » ROE %

Milestone Scientific (Milestone Scientific) ROE % : -101.66% (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Milestone Scientific ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Milestone Scientific's annualized net income for the quarter that ended in Dec. 2023 was $-7.76 Mil. Milestone Scientific's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $7.63 Mil. Therefore, Milestone Scientific's annualized ROE % for the quarter that ended in Dec. 2023 was -101.66%.

The historical rank and industry rank for Milestone Scientific's ROE % or its related term are showing as below:

MLSS' s ROE % Range Over the Past 10 Years
Min: -465.02   Med: -65.68   Max: -16.88
Current: -80.73

During the past 13 years, Milestone Scientific's highest ROE % was -16.88%. The lowest was -465.02%. And the median was -65.68%.

MLSS's ROE % is ranked worse than
84.41% of 808 companies
in the Medical Devices & Instruments industry
Industry Median: 0.25 vs MLSS: -80.73

Milestone Scientific ROE % Historical Data

The historical data trend for Milestone Scientific's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Milestone Scientific ROE % Chart

Milestone Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -465.02 -81.99 -41.87 -65.47 -75.98

Milestone Scientific Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -73.07 -53.09 -101.72 -77.20 -101.66

Competitive Comparison of Milestone Scientific's ROE %

For the Medical Instruments & Supplies subindustry, Milestone Scientific's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Milestone Scientific's ROE % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's ROE % distribution charts can be found below:

* The bar in red indicates where Milestone Scientific's ROE % falls into.



Milestone Scientific ROE % Calculation

Milestone Scientific's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-6.929/( (10.226+8.013)/ 2 )
=-6.929/9.1195
=-75.98 %

Milestone Scientific's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-7.756/( (7.246+8.013)/ 2 )
=-7.756/7.6295
=-101.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Milestone Scientific  (AMEX:MLSS) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-7.756/7.6295
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-7.756 / 9.044)*(9.044 / 10.978)*(10.978 / 7.6295)
=Net Margin %*Asset Turnover*Equity Multiplier
=-85.76 %*0.8238*1.4389
=ROA %*Equity Multiplier
=-70.65 %*1.4389
=-101.66 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-7.756/7.6295
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-7.756 / -7.828) * (-7.828 / -7.92) * (-7.92 / 9.044) * (9.044 / 10.978) * (10.978 / 7.6295)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9908 * 0.9884 * -87.57 % * 0.8238 * 1.4389
=-101.66 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Milestone Scientific ROE % Related Terms

Thank you for viewing the detailed overview of Milestone Scientific's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Milestone Scientific (Milestone Scientific) Business Description

Traded in Other Exchanges
N/A
Address
425 Eagle Rock Avenue, Roseland, NJ, USA, 07068
Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.
Executives
Peter J Milligan officer: President 1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102
Neal I Goldman director 170 SOUTHPORT DRIVE, MORRISVILLE NC 27560
Leslie Bernhard director C/O ADSTAR, INC., 488 S. ROYAL LANE, COPPELL TX 75019
Benedetta I Casamento director 200 CAMPUS DRIVE, FLORHAM PARK NJ 07932
Leonard Osser director, 10 percent owner, officer: CEO
Leonard M Schiller director
Scott L. Kahn officer: Chief Financial Officer 425 EAGLE ROCK AVENUE, SUITE 403, ROSELAND NJ 07068
Giandomenico Trombetta director, 10 percent owner CORSO VENEZIA 44, MILAN L6 20121
Joseph D'agostino officer: CFO & COO C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039
Jan Adriaan Haverhals officer: President 110 WHITE ROCK ROAD, APT. 3304, VERONA NJ 07044
Brent W Johnston officer: President C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE SUITE 102, LIVINGSTON NJ 07039
Michael Mcgeehan director C/O MILESTONE SCIENTIFIC INC, LIVINGSTON NJ 07039
Edward J. Zelnick director C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039
Daniel S Goldberger officer: President and CEO 24 CARPENTER ROAD, CHESTER NY 10918
Bp4 S.r.l. director, 10 percent owner, officer: See Remarks CORSO VENEZIA 44, MILAN L6 20121

Milestone Scientific (Milestone Scientific) Headlines